Eric A. Hughes, MD, PhD in

Eric A. Hughes, MD, PhD

Login to view DISC.
Member Board of Directors at Monte Rosa Therapeutics
📍 Parsippany, New Jersey, United States

As Tevas EVP of Global R&D and CMO, Eric Hughes leads a 4, 000-person team developing innovative medicines in neuroscience and immunology. This Yale-educated MD/PhD serves on the board of Monte Rosa Therapeutics, leveraging two decades of experience from Novartis and Vertex to drive groundbreaking therapies.

Eric is motivated by a mission to translate science into impactful treatments, often sharing inspirational quotes from figures like William Blake and Albert Einstein. He values collaboration and emphasizes surrounding himself with intelligent, curious people to foster a mindset where anything is possible.

His R&D organizations work directly impacts the health of nearly 200 million people every single day.

Read the full overview →
Experience
26 Years
Current Role
Member Board of Directors
Job Level
Leadership
Location
Parsippany, New Jersey, United States
Personality Overview

How Eric shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Eric cares about

R&D Innovation
He is leading Teva's transformation from a generics-focused company to a driver of innovation in neuroscience and immunology through a "Pivot to Growth" strategy.
Strategic Partnerships
Actively seeks external collaborations with biotech leaders to complement Teva's internal expertise and accelerate the advancement of science for patients.
+5 more topics Login to view topics
Career

Work history

12-2024
Member Board of Directors
Monte Rosa Therapeutics
7-2022
Executive Vice President Global R&D and Chief Medical Officer
Teva Pharmaceuticals
9-2021 - 7-2022
Senior Vice President, Clinical Development and Translational Medicine
Vertex Pharmaceuticals
9-2020 - 8-2021
Global Head, Clinical Development and Analytics
Novartis
10-2018 - 9-2020
Global Development Unit Head, Immunology, Hepatology & Dermatology and China Region Development Head
Novartis
In the press

Media appearances

Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors. Featured in GlobeNewswire
See now
Monte Rosa Therapeutics appoints Hughes to board of directors. Featured in Nasdaq
+2 more appearances Login to view media
Education
1991 - 1999
MD / PhD
Yale School of Medicine
1987 - 1991
Bachelor of Science (BS)
Haverford College
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Monte Rosa Therapeutics Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Eric. Free, 10 seconds.